Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003527141 | SCV004291872 | uncertain significance | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 2023-07-03 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 1291 of the EP300 protein (p.Lys1291Thr). This variant has not been reported in the literature in individuals affected with EP300-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. |
Breakthrough Genomics, |
RCV004696550 | SCV005194491 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
3billion | RCV004723372 | SCV005328988 | likely benign | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency; Colorectal cancer; Menke-Hennekam syndrome 2 | 2024-09-20 | criteria provided, single submitter | clinical testing | The variant was identified in at least one patient who was diagnosed with a different variant in another gene and showed no symptoms related to the gene containing the variant in question. |